NOTICE: Thank you for visiting our site. Your experience is important to us. We're upgrading our system to better serve you. During this time, purchases and member logins will be unavailable. Full functionality will be restored by Monday, 29 July.
WuXi Biologics in Dundalk, Ireland, is contract research development and manufacturing (CRDMO) facility using hybrid, single-use, scale-out production technology for multiproduct mAb and recombinant protein drug substance. The site also houses innovative Manufacturing Science & Technology labs that supports customers with manufacturing capacity as well as product research and optimization.
This new 467,500-square-foot greenfield facility includes 2 manufacturing areas utilizing 6x1KL single-use (SU) bioreactors for perfusion and 12x4KL SU fed-batch bioreactors, making it one of the largest facilities of its kind in Europe.